R T Bryan

Summary

Country: UK

Publications

  1. ncbi Socio-economic deprivation and survival in bladder cancer
    Gulnaz Begum
    Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, University of Birmingham, Birmingham, UK
    BJU Int 94:539-43. 2004
  2. ncbi Narrow-band imaging flexible cystoscopy in the detection of recurrent urothelial cancer of the bladder
    Richard T Bryan
    Department of Public Health and Epidemiology, University of Birmingham, Birmingham, UK
    BJU Int 101:702-5; discussion 705-6. 2008
  3. doi Cadherin switching dictates the biology of transitional cell carcinoma of the bladder: ex vivo and in vitro studies
    R T Bryan
    Department of Public Health and Epidemiology, University of Birmingham, UK
    J Pathol 215:184-94. 2008
  4. ncbi Molecular pathways in bladder cancer: part 2
    Richard T Bryan
    The Epithelial Laboratory, Division of Medical Sciences, The Queen Elizabeth Hospital, Birmingham, UK
    BJU Int 95:491-6. 2005
  5. pmc Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential
    R T Bryan
    School of Cancer Sciences, University of Birmingham, Birmingham B15 2TT, UK
    Br J Cancer 110:679-85. 2014
  6. ncbi The role of beta-catenin signaling in the malignant potential of cystitis glandularis
    R T Bryan
    Epithelial Laboratory, University of Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, UK
    J Urol 170:1892-6. 2003
  7. ncbi 'Superficial' bladder cancer - time to uncouple pT1 tumours from pTa tumours
    R T Bryan
    Department of Urology The Queen Elizabeth Hosptial and the Epithelial Laboratory, The University of Birmingham, Birmingham, UK
    BJU Int 90:846-52. 2002
  8. ncbi Narrow-band imaging flexible cystoscopy: a new user's experience
    Richard T Bryan
    Department of Public Health, Epidemiology and Biostatistics, and School of Cancer Sciences, University of Birmingham, Birmingham, United Kingdom
    J Endourol 24:1339-43. 2010
  9. ncbi Molecular pathways in bladder cancer: part 1
    Richard T Bryan
    The Epithelial Laboratory, Division of Medical Sciences, The Queen Elizabeth Hospital, Birmingham, UK
    BJU Int 95:485-90. 2005
  10. doi Biomarkers in bladder cancer
    Richard T Bryan
    Department of Public Health Epidemiology and Biostatistics, School of Population Sciences, University of Birmingham, Birmingham, UK
    BJU Int 105:608-13. 2010

Collaborators

Detail Information

Publications17

  1. ncbi Socio-economic deprivation and survival in bladder cancer
    Gulnaz Begum
    Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, University of Birmingham, Birmingham, UK
    BJU Int 94:539-43. 2004
    ....
  2. ncbi Narrow-band imaging flexible cystoscopy in the detection of recurrent urothelial cancer of the bladder
    Richard T Bryan
    Department of Public Health and Epidemiology, University of Birmingham, Birmingham, UK
    BJU Int 101:702-5; discussion 705-6. 2008
    ....
  3. doi Cadherin switching dictates the biology of transitional cell carcinoma of the bladder: ex vivo and in vitro studies
    R T Bryan
    Department of Public Health and Epidemiology, University of Birmingham, UK
    J Pathol 215:184-94. 2008
    ..The results provide evidence that increased P-cadherin expression promotes a more malignant and invasive phenotype of bladder cancer, and appears to have a novel role late in the disease...
  4. ncbi Molecular pathways in bladder cancer: part 2
    Richard T Bryan
    The Epithelial Laboratory, Division of Medical Sciences, The Queen Elizabeth Hospital, Birmingham, UK
    BJU Int 95:491-6. 2005
  5. pmc Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential
    R T Bryan
    School of Cancer Sciences, University of Birmingham, Birmingham B15 2TT, UK
    Br J Cancer 110:679-85. 2014
    ..The mechanisms and effects of EpCAM cleavage in bladder cancer are worthy of further investigation, and may identify novel therapeutic targets. ..
  6. ncbi The role of beta-catenin signaling in the malignant potential of cystitis glandularis
    R T Bryan
    Epithelial Laboratory, University of Birmingham, Queen Elizabeth Hospital, Edgbaston, Birmingham B15 2TH, UK
    J Urol 170:1892-6. 2003
    ..Etiologically and histologically cystitis glandularis mimics Barrett's metaplasia. We investigated the roles of beta-catenin and TNFalpha in cystitis glandularis...
  7. ncbi 'Superficial' bladder cancer - time to uncouple pT1 tumours from pTa tumours
    R T Bryan
    Department of Urology The Queen Elizabeth Hosptial and the Epithelial Laboratory, The University of Birmingham, Birmingham, UK
    BJU Int 90:846-52. 2002
  8. ncbi Narrow-band imaging flexible cystoscopy: a new user's experience
    Richard T Bryan
    Department of Public Health, Epidemiology and Biostatistics, and School of Cancer Sciences, University of Birmingham, Birmingham, United Kingdom
    J Endourol 24:1339-43. 2010
    ..We investigated whether a "new user" of NBI flexible cystoscopy, previously unfamiliar with this technique, could reproduce these results...
  9. ncbi Molecular pathways in bladder cancer: part 1
    Richard T Bryan
    The Epithelial Laboratory, Division of Medical Sciences, The Queen Elizabeth Hospital, Birmingham, UK
    BJU Int 95:485-90. 2005
  10. doi Biomarkers in bladder cancer
    Richard T Bryan
    Department of Public Health Epidemiology and Biostatistics, School of Population Sciences, University of Birmingham, Birmingham, UK
    BJU Int 105:608-13. 2010
    ..As part of the ongoing quality-assurance process for BCPP we present an updated review of our selected biomarkers, as well as highlighting other recent important developments in bladder cancer research...
  11. ncbi Laparoscopic peritoneal lavage in staging gastric and oesophageal cancer
    R T Bryan
    The Institute for Cancer Studies, The University of Birmingham, Birmingham, UK
    Eur J Surg Oncol 27:291-7. 2001
    ..Log-rank Chi(2)=16.7, P<0.001. CONCLUSIONS: The presence of FPTCs detected by our technique is a contraindication to attempted curative resection - palliation only (medical or surgical) is appropriate...
  12. pmc Combined proteome and transcriptome analyses for the discovery of urinary biomarkers for urothelial carcinoma
    N J Shimwell
    School of Cancer Sciences, University of Birmingham, Birmingham B15 2TT, UK
    Br J Cancer 108:1854-61. 2013
    ..We have tested combining gene expression profiling of tumours with proteomic analysis of cancer cell line secretomes as a strategy to discover urinary biomarkers for bladder cancer...
  13. ncbi Delay and survival in bladder cancer
    D M A Wallace
    Department of Urology, The Queen Elizabeth Hospital, Birmingham, UK
    BJU Int 89:868-78. 2002
    ....
  14. ncbi Axillary lipoblastoma--tumor recurrence in the right atrium
    R M Abel
    Department of Paediatric Surgery, Diana Princess of Wales Children s Hospital, Birmingham, England, UK
    J Pediatr Surg 38:1246-7. 2003
    ..The importance of cytogenetics in the diagnosis of lipoblastoma is emphasized, as is the need to be wary of the diagnosis of lipoma in infancy...
  15. doi Cadherin switching and bladder cancer
    Richard T Bryan
    School of Cancer Sciences, University of Birmingham, Birmingham, United Kingdom
    J Urol 184:423-31. 2010
    ..We introduce some of the concepts of cadherin mediated cell adhesion and biology, and describe cadherin switching in detail for bladder cancer...
  16. pmc Mechanisms of recurrence of Ta/T1 bladder cancer
    Richard T Bryan
    Department of Public Health, Epidemiology and Biostatistics, School of Population Sciences, University of Birmingham, Birmingham, UK
    Ann R Coll Surg Engl 92:519-24. 2010
    ..However, the relative importance and timing of these mechanisms is currently unknown. Our objective was to postulate the incidence and timing of these mechanisms by investigating the location of bladder cancer recurrences over time...
  17. doi The West Midlands Bladder Cancer Prognosis Programme: rationale and design
    Maurice P Zeegers
    Department of Public Health, Epidemiology and Biostatistics, University of Birmingham, Birmingham, UK
    BJU Int 105:784-8. 2010
    ..This might represent a model for the future investigation of urological and other malignancies...